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AmpC -lactamase producing Escherichia coli
associated with urinary tract infection from a
tertiary health care centre in North East India
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Bhattacharjee1
1 Assam University, Silchar, Assam, India
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Background: Escherichia coli are the major causes of urinary
tract infection (UTI) and an emerging problem worldwide. These
organisms harbouring AmpC beta-lactamase is a major cause of
therapeutic failure leaving cephalosporins inactive along with co-
existing mechanism of resistance. The aim of this study was to
investigate the prevalence of Escherichia coli producing AmpC beta-
lactamase in UTI and analyse their antibiotic susceptibility pattern
from a tertiary care hospital in North Eastern part of India.
Methods & Materials: A total of 126 Escherichia coli were
biochemically identiﬁed from a 293 consecutive non repetitive
clini-cal isolates which were obtained from patient with UTI over a
period of 12months (February2013 to January 2014). Isolates were
initially screened with cefoxitin (30g) and conﬁrmed for produc-
tion of AmpC beta-lactamases by M3DET. Phenotypically positive
isolates were further conﬁrmed by multiplex PCR targeting blaCIT,
blaACC, blaEBC, blaDHA, blaFOX, blaMOX families Antimicrobial suscep-
tibility and MIC’s were also determined as per CLSI guideline.
Results: Out of 126 Escherichia coli isolates 97(76.9%) were
found to be cefoxitin resistant and among them 46 (47.4%) iso-
lates were conﬁrmed to be AmpC producers. Most of the AmpC
positive isolates were found to be signiﬁcantly multi-drug resis-
tant and their minimum inhibition concentrations were above the
break point. Out of 46 isolates 39 (84.7%) showed genotypically
positive for blaAmpCgenes (24CIT, 12DHA and 3EBC).
Conclusion: In the present study AmpC -lactamase produc-
tion is accompanied bymulti drug resistance therefore, therapeutic
options become limited resulting a need for new measures for the
management of Escherichia coli causing urinary tract infections
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Antibiotic resistance among hospitalized
patients in Mauritius in 2014
M. Issack
Victoria Hospital, Quatre-Bornes, Mauritius
Background: A retrospective survey of bacteria isolated from
hospitalised patients in Mauritius in July 2014 was conducted to
obtain updated information on the extent of antimicrobial resis-
tance in the country
Methods & Materials: Results of all specimens of urine, pus
swab, blood culture, tracheal secretion and intravascular catheter
originating fromhospitalwards andprocessedat theCentralHealth
Laboratory and at Jeetoo Hospital Laboratory in July 2014 were
reviewed and analysed. Duplicate isolates from the same patient
were excluded. Organisms considered likely to be normal ﬂora or
contaminants were not considered.
Results: Of 686gram-negative bacteria recorded, themost com-
monwere E.coli (183),Klebsiella spp. (118), Pseudomonas aeruginosa
(93), Acinetobacter spp. (78) and Proteus spp. (61). Most isolates
were obtained from pus swabs (47%) and urine (25%) but tracheal
secretion was the source of 32% of Acinetobacter spp. Percentage
susceptibility to cefotaxime, ciproﬂoxacin, gentamicin, amikacin,
meropenem and colistin was 54%, 42%, 73%, 93%, 97% and 100%
respectively in E.coli, with corresponding ﬁgures of 42%, 47%, 57%,
81%, 91% and 100% respectively in Klebsiella spp., 6%, 18%, 21%,42%,
26% and 100% respectively in Acinetobacter spp., and 64%, 72%,
64%, 89%, 100% and 0% respectively in Proteus spp. Less than
three-quarters of P. aeruginosa isolateswere susceptible to gentam-
icin (58%), ciproﬂoxacin (53%), ceftazidime (70%), amikacin (71%),
imipenem (73%) andmeropenem (73%) but 89%were susceptible to
piperacillin-tazobactam combination and 100% to colistin. Of 308
signiﬁcant Gram-positive isolates recorded, Staphylococcus aureus
(140) and Enterococcus spp. (96) were most commonly encoun-
tered. Only 61% of S. aureus isolates were susceptible tomethicillin,
but 69% and 100% were susceptible to erythromycin and van-
comycin respectively. S.aureus was isolated from blood cultures of
27 patients, of which 5 (19%) were methicillin-resistant (MRSA).
Of 96 enterococci recorded, 92% were susceptible to ampicillin and
none was vancomycin-resistant.
Conclusion: Resistance to broad-spectrum antibiotics is com-
mon among Gram-negative bacteria and S.aureus isolated from
hospitalised patients in Mauritius. Therapeutic options to treat
many infections in hospitalized patients are now limited. There is a
need for effective infection control and antibiotic stewardship pro-
grams to slow the emergence and spread of microorganisms with
acquired resistance mechanisms.
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